Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

Chronic Pain Master Protocol (CPMP): A Study of LY3526318 in Participants With Chronic Low Back Pain

ClinicalTrials.gov ID: NCT05086289

Public ClinicalTrials.gov record NCT05086289. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 23, 2026, 6:30 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

Randomized Placebo-controlled Phase 2 Clinical Trial to Evaluate LY3526318 for the Treatment of Chronic Low Back Pain

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

The purpose of this study is to test whether LY3526318 is efficacious and safe in relieving chronic low back pain (CLBP). This trial is part of the chronic pain master protocol H0P-MC-CPMP (NCT05986292) which is a protocol to accelerate the development of new treatments for chronic pain.

Study identification

NCT ID
NCT05086289
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Eli Lilly and Company
Industry
Enrollment
159 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 25, 2021 (Actual)
Primary completion
Jun 17, 2022 (Actual)
Completion
Jun 17, 2022 (Actual)
Last update posted
Oct 5, 2023

2021 – 2022

United States locations

U.S. sites
29
U.S. states
13
U.S. cities
27
Facility City State ZIP Site status
Synexus- Chandler Chandler Arizona 85224 —
Synexus Clinical Research - Glendale Glendale Arizona 85306 —
Alliance for Multispecialty Research, LLC Tempe Tempe Arizona 85281 —
Artemis Institute for Clinical Research Riverside California 92503 —
Artemis Institute for Clinical Research San Diego California 92103 —
CMR of Greater New Haven Hamden Connecticut 06517 —
VIN-Julie Schwartzbard Aventura Florida 33180 —
Suncoast Research Group Miami Florida 33135 —
New Horizon Research Center Miami Florida 33165 —
Renstar Medical Research Ocala Florida 34470 —
Synexus Clinical Research US, Inc - Orlando Orlando Florida 32806 —
Synexus Clinical Research US, Inc. Pinellas Park Florida 33781 —
Synexus Clinical Research US, Inc. The Villages Florida 32162 —
Rocky Mountain Clinical Research Idaho Falls Idaho 83404 —
Synexus Clinical Research US, Inc. Chicago Illinois 60602 —
Northwestern University Chicago Illinois 60611 —
Boston Clinical Trials Boston Massachusetts 02131 —
ActivMed Practices and Research Methuen Massachusetts 01844 —
MedVadis Research Corporation Waltham Massachusetts 02451 —
Great Lakes Research Group, Inc. Bay City Michigan 48706 —
StudyMetrix Research City of Saint Peters Missouri 63303 —
Clinvest Research LLC Springfield Missouri 65807 —
Synexus - Cincinnati Cincinnati Ohio 45236 —
META Medical Research Institute Dayton Ohio 45432 —
Altoona Center For Clinical Research Duncansville Pennsylvania 16635 —
FutureSearch Trials Austin Texas 78731 —
Synexus - US San Antonio Texas 78229 —
Northwest Clinical Research Center Bellevue Washington 98007 —
Rainier Clinical Research Center Renton Washington 98057 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 2 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT05086289, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Oct 5, 2023 · Synced Oct 23, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT05086289 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →